Destroyed lung due to sustained inflammation after chemoradiotherapy followed by durvalumab

A 68‐year‐old male patient with squamous cell carcinoma (cT4N2M0) of the left upper lobe received chemoradiotherapy followed by durvalumab, an immune checkpoint inhibitor. The tumour responded well to the therapy, but an infiltrative shadow appeared in the left upper lobe, which was outside the radi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Respirol Case Rep
Asıl Yazarlar: Taima, Kageaki, Tanaka, Hisashi, Itoga, Masamichi, Ishioka, Yoshiko, Kurose, Akira, Tasaka, Sadatomo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Ltd 2020
Konular:
Case Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7211830/
https://ncbi.nlm.nih.gov/pubmed/32399215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.580
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller